DAVID MANSOURI to Mass Screening
This is a "connection" page, showing publications DAVID MANSOURI has written about Mass Screening.
Connection Strength
0.813
-
A comparison of tumour and host prognostic factors in screen-detected vs nonscreen-detected colorectal cancer: a contemporaneous study. Colorectal Dis. 2016 Oct; 18(10):967-975.
Score: 0.326
-
Route to diagnosis of colorectal cancer and association with survival within the context of a bowel screening programme. Public Health. 2022 Oct; 211:53-61.
Score: 0.123
-
Relationship between BMI, CT-derived body composition and colorectal neoplasia in a bowel screening population. Scott Med J. 2022 Aug; 67(3):93-102.
Score: 0.120
-
Lower morbidity and improved outcomes in patients with screen-detected colorectal cancer. Rev Esp Enferm Dig. 2017 06 26; 109(7):483-484.
Score: 0.086
-
The impact of aspirin, statins and ACE-inhibitors on the presentation of colorectal neoplasia in a colorectal cancer screening programme. Br J Cancer. 2013 Jul 09; 109(1):249-56.
Score: 0.065
-
The impact of age, sex and socioeconomic deprivation on outcomes in a colorectal cancer screening programme. PLoS One. 2013; 8(6):e66063.
Score: 0.065
-
The role of faecal calprotectin in the identification of colorectal neoplasia in patients attending for screening colonoscopy. Colorectal Dis. 2022 02; 24(2):188-196.
Score: 0.029